Margins of excision for cutaneous melanoma of the eyelid skin - The collaborative eyelid skin melanoma group report

Ophthalmic Plastic and Reconstructive Surgery

Volumn 19, Issue 2, 2003, Pages 96-101

  Esmaeli, Bita ^a   Youssef, Adel ^a   Naderi, Aresu ^a   Ahmadi, M Amir ^a   Meyer, Dale R ^b   McNab, Alan ^c  

^a UNIVERSITY OF TEXAS   (United States)

^b ALBANY MEDICAL COLLEGE   (United States)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; AGED; ARTICLE; BRESLOW THICKNESS; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER LOCALIZATION; CANCER RECURRENCE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; EYELID; FEMALE; FOLLOW UP; GENDER; HEALTH SURVEY; HUMAN; INFORMATION; LYMPH NODE METASTASIS; MALE; METASTASIS; PATIENT CODING; PRIORITY JOURNAL; PROGNOSIS; REGRESSION ANALYSIS; RELIABILITY; RETROSPECTIVE STUDY; SKIN CANCER; SKIN INCISION; SKIN SCAR; SKIN SURGERY; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; EYELID NEOPLASMS; FEMALE; HUMANS; LYMPHATIC METASTASIS; MALE; MELANOMA; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; OPHTHALMOLOGY; PHYSICIAN'S PRACTICE PATTERNS; RETROSPECTIVE STUDIES; SKIN NEOPLASMS;

EID: 0037344180     PISSN: 07409303     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.IOP.0000056141.97930.E8     Document Type: Article

References (16)

1. Rodriguez-Sains RS, Jakobiec FA. Eyelid and conjunctival neoplasms. In: Nesi F, Lisma R, Levine M, eds. Smith's Ophthalmic Plastic and Reconstructive Surgery. St. Louis, Mo: CV Mosby; 1998:559-75.
2. Balch CM, Buzaid AC, Soong SJ, et al. Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma. J Clin Oncol 2001;19:3635-48.
3. Kane WJ, Yugueros P, Clay RP, et al. Treatment outcome for 424 primary cases of clinical stage I cutaneous malignant melanoma of the head and neck. Head Neck 1997;19:457-65.
4. O'Brien CJ, Coates AS, Petersen-Schaefer K, et al. Experience with 998 cutaneous melanomas of the head and neck over 30 years. Am J Surg 1991;162:310-4.
5. Esmaeli B, Wang B, Deavers M, et al. Prognostic factors for survival in malignant melanoma of the eyelid skin. Ophthal Plast Reconstr Surg 2000;16:250-7.
6. StataCorp. 2001. Stata Statistical Software: Release 7.0. College Station. TX: Stata Corporation.
7. Vaziri M, Buffam FV, Matrinka M, et al. Clinicopathologic features and behavior of cutaneous eyelid melanoma. Ophthalmology 2002;109:901-8.
8. Veronesi U, Cascinelli N. Narrow excision (1-cm margin): a safe procedure for thin cutaneous melanoma. Arch Surg 1991;126:438-41.
9. Karakousis CP, Balch CM, Urist MM, et al. Local recurrence in malignant melanoma: long-term results of the multi-institutional randomized surgical trial. Ann Surg Oncol 1996;3:446-52.
10. Balch CM, Soon SJ, Smith T, et al. Long-term results of a prospective surgical trial comparing 2 cm vs 4 cm excision margins for 740 patients with 1-4 mm melanomas. Ann Surg Oncol 2001;8:101-8.
11. Aitken DR, James AG, Carey LC. Local cutaneous recurrence after conservative excision of malignant melanoma. Arch Surg 1984;119:643-6.
12. NIH Consensus Development Panel on Early Melanoma. Diagnosis and treatment of early melanoma. JAMA 1992:;68:1314-9.
13. Breslow A. Prognostic factors in the treatment of cutaneous melanoma. J Cutan Pathol 1979;6:208-12.
14. Balch CM. Soong SJ, Gershenwald JE, et al. Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system. J Clin Oncol 2001;19:3622-34.
15. Veronesi U. Cascinelli N, Adamus J, et al. Thin stage I primary cutaneous malignant melanoma: comparison of excision with margins of 1 or 3 cm. N Engl J Med 1988;318:1159-62.
16. Balch CM, Urist MM, Karakcusis CP, et al. Efficacy of 2 cm surgical margins for intermediate-thickness melanomas (1-4 mm): results of a multi-institutional randomized surgical trial. Ann Surg 1993;218:262-7.